Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Bellus Health Inc (BLU.TO)

Bellus Health Inc (BLU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health Newswire.ca - Wed Jun 28, 2023

/CNW/ - GSK plc (LSE: GSK) (NYSE: GSK) and BELLUS Health Inc. (TSX: BLU) NASDAQ: BLU) today announced GSK has completed the acquisition of BELLUS, a...

BLU : 14.74 (unch)
GSK.LN : 1,733.500 (+0.29%)
GSK : 43.40 (-0.23%)
BLU.TO : 19.48 (-0.10%)
Bellus: Q1 Earnings Snapshot AP - Fri May 12, 2023

Bellus: Q1 Earnings Snapshot

BLU.TO : 19.48 (-0.10%)
BELLUS Health Announces Meeting Updates Business Wire - Wed Apr 26, 2023

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“ BELLUS Health ” or the “ Company ”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...

BLU : 14.74 (unch)
BLU.TO : 19.48 (-0.10%)
Stocks Start out Downward Baystreet - Wed Apr 19, 2023

Equities in Toronto declined at the open on Wednesday as miners and oil companies tracked commodity ...

BLU.TO : 19.48 (-0.10%)
Stocks in play: BELLUS Health Inc Baystreet - Tue Apr 18, 2023

Announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, ...

BLU.TO : 19.48 (-0.10%)
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health Business Wire - Tue Apr 18, 2023

GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical...

BLU : 14.74 (unch)
GSK : 43.40 (-0.23%)
GSK.LN : 1,733.500 (+0.29%)
BLU.TO : 19.48 (-0.10%)
GSK signs deal to buy Canadian drug developer Bellus Health for US$2 billion Canadian Press - Tue Apr 18, 2023

TORONTO — GSK plc has announced a deal to buy Canadian drug developer Bellus Health Inc. for US$2 billion.

BLU.TO : 19.48 (-0.10%)
TSX Finds Strength at Daily Close, Venture Down on Week Baystreet - Thu Apr 6, 2023

Stocks remained volatile in Canada’s biggest market, but fought their way to positive reading Thursday, ...

BLU.TO : 19.48 (-0.10%)
Stocks in play: BELLUS Health Inc. Baystreet - Wed Apr 5, 2023

Announced positive data from its Phase 1 bioavailability equivalence study evaluating a once-daily Extended-Release ...

BLU.TO : 19.48 (-0.10%)
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation Business Wire - Wed Apr 5, 2023

BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company working to better the lives of patients suffering from persistent cough,...

BLU : 14.74 (unch)
BLU.TO : 19.48 (-0.10%)

Barchart Exclusives

NVIDA Stock Is Still Undervalued, and Shorting Its Put Options Are Still are Great Income Play Barchart - 20 minutes ago
Nvidia stock still looks undervalued here, even though the stock keeps rising. This is based on higher analyst revenue and FCF estimates. This creates a good short-put play, especially for existing investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot